Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Pediatric Intensive Care Unit, Division of Critical Care, Queensland Children's Hospital, Children's Health Queensland, Brisbane, QLD, Australia.
Pediatr Crit Care Med. 2019 Jan;20(1):e46-e50. doi: 10.1097/PCC.0000000000001757.
Reduction of nosocomial infections represents an increasingly recognized aspect of PICU benchmarking. We investigated the prevalence and outcomes of viral respiratory infections acquired during admission to PICU.
Multicenter, statewide retrospective linkage study.
Tertiary PICU.
All children less than 16 years requiring PICU admission for greater than 48 hours from January 1, 2008, until December 31, 2013.
Testing was performed in symptomatic patients using an extended panel polymerase chain reaction capturing nine respiratory viruses. Duration of intubation and total duration of respiratory support were primary outcomes.
Of 3,607 patients admitted to PICU for greater than 48 hours, 102 (2.8%) were diagnosed with a PICU-associated viral infection out of 702 patients (19.4%) undergoing viral testing, reflecting a rate of 2.8 PICU-associated viral infections per 1,000 PICU patient days. Compared with negative/untested patients, those with PICU-associated viral infections had greater intubation duration (median 164 vs 67; p< 0.001), longer respiratory support (204 vs 68 hr; p < 0.001), were more likely to require extracorporeal life support (odds ratio, 5.3; 2.7-10.3; p < 0.001), high-frequency oscillatory ventilation (odds ratio, 3.0; 1.7-5.4; p < 0.001), and inhaled nitric oxide (odds ratio, 2.7; 1.5-5.0; p = 0.001). When comparing patients with PICU-associated viral infection with patients who tested negative for respiratory viruses, no substantial difference in these outcomes was found.
The acquisition of viral infections during PICU admission is less frequent compared with previous reports on bacterial and fungal hospital-acquired infections. We did not observe worse patient-centered outcomes when comparing virus positive versus tested but negative patients. Our findings challenge the clinical value of performing viral respiratory diagnostics in PICU patients evaluated for infection.
减少医院感染是儿科重症监护病房(PICU)基准测试中日益受到重视的一个方面。我们调查了在 PICU 住院期间获得的病毒性呼吸道感染的发生率和结果。
多中心、全州范围的回顾性关联研究。
三级 PICU。
所有需要 PICU 住院治疗超过 48 小时且年龄小于 16 岁的儿童,时间为 2008 年 1 月 1 日至 2013 年 12 月 31 日。
对症状性患者使用扩展的聚合酶链反应检测试剂盒进行检测,该试剂盒可捕获九种呼吸道病毒。主要结果为气管插管时间和总呼吸支持时间。
在 3607 名在 PICU 住院超过 48 小时的患者中,102 名(2.8%)在接受病毒检测的 702 名患者(19.4%)中诊断为与 PICU 相关的病毒感染,反映出每 1000 名 PICU 患者日发生 2.8 例与 PICU 相关的病毒感染。与阴性/未检测患者相比,与 PICU 相关的病毒感染者气管插管时间更长(中位数 164 比 67;p<0.001),呼吸支持时间更长(204 比 68 小时;p<0.001),更有可能需要体外生命支持(比值比,5.3;2.7-10.3;p<0.001)、高频振荡通气(比值比,3.0;1.7-5.4;p<0.001)和吸入一氧化氮(比值比,2.7;1.5-5.0;p=0.001)。当比较与 PICU 相关的病毒感染患者与呼吸道病毒检测阴性的患者时,在这些结局方面没有发现实质性差异。
与先前关于细菌和真菌医院获得性感染的报告相比,在 PICU 住院期间获得病毒感染的频率较低。当比较病毒阳性与检测但阴性的患者时,我们没有观察到更差的以患者为中心的结局。我们的研究结果对在疑似感染的 PICU 患者中进行病毒呼吸道诊断的临床价值提出了质疑。